echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature Sub-Journal: LINC00842 promotes the malignant progression of pancreatic cancer through metabolic remodeling

    Nature Sub-Journal: LINC00842 promotes the malignant progression of pancreatic cancer through metabolic remodeling

    • Last Update: 2021-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The molecular mechanism of pancreatic ductal adenocarcinoma (PDAC) is unclear


    Pancreatic ductal carcinoma is one of the most deadly malignant tumors, with a 5-year survival rate of <9%


    Recent studies have shown that many oncogenes and mutated tumor suppressor genes, such as c-myc and p53, are involved in regulating tumor cell metabolism


    Long intergenic non-coding RNAs (LincRNAs) are a type of biological process regulators, which have been shown to play a role in metabolic regulation


    Peroxisome proliferator-activated receptor gamma co-activator 1-α (pPARGC1A or pgc-1α) is the main transcriptional co-regulator involved in metabolic remodeling


    In this study, the authors identified a metabolic remodeling ncRNA LINC00842 in PDAC, which can be induced by high glucose, which is a risk factor for the occurrence of PDAC


    references

    Xudong Huang et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.